Tumor type, stage of progression, and TME features are important factors that determine the effect of IL-1 on cancer; for example, in the context of malignancy, IL-1α and IL-1β predominantly facilitate tumor growth; however, during early malignant transformation, they may exhibit antitumor properties (61). This evidence concerns the gene IL1A and cancer.